RECURRENT HEAD AND NECK CANCER

Clinical trials for RECURRENT HEAD AND NECK CANCER explained in plain language.

Never miss a new study

Get alerted when new RECURRENT HEAD AND NECK CANCER trials appear

Sign up with your email to follow new studies for RECURRENT HEAD AND NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 2 Completed 1

New combo therapy aims to supercharge immune system against HPV cancer

Disease control Completed

This study tested whether adding a new immunotherapy called PDS0101 to an existing drug (pembrolizumab) could better treat advanced head and neck cancer caused by HPV16. It involved 95 adults whose cancer had returned or spread. The goal was to see if the combination could help t…

Matched conditions: RECURRENT HEAD AND NECK CANCER

Phase: PHASE2 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

RECURRENT HEAD AND NECK CANCER

Get alerted when new RECURRENT HEAD AND NECK CANCER trials appear

New combo therapy aims to supercharge immune system against HPV cancer